These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3473646)

  • 1. The effect of bromhexine on the kidney lesions in NZB-NZW-F1 mice.
    Prause JU; Elling F; Jensen OA; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():286-90. PubMed ID: 3473646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of bromhexine in Sjögren's syndrome.
    Avisar R; Savir H; Machtey I; Ovaknin L; Shaked P; Menache R; Allalouf D
    Ann Ophthalmol; 1981 Aug; 13(8):971-3. PubMed ID: 7027873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bromhexine, ambroxol, and placebo on clinical and histopathological changes in "Sjögren" mice.
    Prause JU; Jensen OA; Manthorpe R
    Graefes Arch Clin Exp Ophthalmol; 1985; 223(5):259-64. PubMed ID: 4065592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Sjogren's syndrome with bromhexine].
    Kaarela K
    Duodecim; 1978; 94(23):1510-2. PubMed ID: 729500
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bromhexine induced remission in a patient with Sjögren's syndrome].
    Isager H; Frost-Larsen K; Manthorpe R
    Ugeskr Laeger; 1977 Dec; 139(50):3003-4. PubMed ID: 595196
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of nandrolone decanoate on Sjögren's syndrome like disorders in NZB/NZW mice.
    Schot LP; Verheul HA; Schuurs AH
    Clin Exp Immunol; 1984 Sep; 57(3):571-4. PubMed ID: 6467680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sjörgren's syndrome treated with bromhexine: a randomised clinical study.
    Frost-Larsen K; Isager H; Manthorpe R
    Br Med J; 1978 Jun; 1(6127):1579-81. PubMed ID: 350346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of bromhexine as a treatment regimen in Sjögren's syndrome-like disease in the NOD (non-obese diabetic) mouse.
    Nanni JM; Nguyen KH; Alford CE; Robinson CP; Stewart CM; Maeda N; Humphreys-Beher MG
    Clin Exp Rheumatol; 1997; 15(5):515-21. PubMed ID: 9307859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren's syndrome treated with bromhexine: a reassessment.
    Manthorpe R; Frost-Larsen K; Isager H; Prause JU
    Br Med J; 1980 Nov; 281(6249):1216-7. PubMed ID: 7427642
    [No Abstract]   [Full Text] [Related]  

  • 11. A follow-up study of the progress of keratoconjunctivitis sicca and response to treatment in primary Sjögren's syndrome.
    Kriegbaum NJ; von Linstow M; Oxholm P; Prause JU
    Scand J Rheumatol; 1989; 18(4):193-6. PubMed ID: 2799300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's syndrome treated with bromhexine: a reassessment.
    Tapper-Jones LM; Aldred MJ; Cadogan SJ; Walker DM; Dolby AE; Hopkins R; Nuki G; Beck L
    Br Med J; 1980 Jun; 280(6228):1356. PubMed ID: 7388541
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of bromhexin on the functional deficiency of the lacrimal apparatus and the salivary glands in Sjogren's syndrome].
    Isager H; Frost-Larsen K; Manthorpe R; Westergaard L
    Med Monatsschr; 1977 Dec; 31(12):582-3. PubMed ID: 593225
    [No Abstract]   [Full Text] [Related]  

  • 15. Sjögren's syndrome, bromhexine, and tear secretion.
    Mackie I; Seal DV
    Br Med J; 1978 Aug; 2(6137):638. PubMed ID: 698633
    [No Abstract]   [Full Text] [Related]  

  • 16. Lacrimal and salivary secretion in Sjögren's syndrome: the effect of systemic treatment with bromhexine.
    Prause JU; Frost-Larsen K; Høj L; Isager H; Manthorpe R
    Acta Ophthalmol (Copenh); 1984 Jun; 62(3):489-97. PubMed ID: 6380205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bromhexine on Sjögren's syndrome accompanied by rheumatoid arthritis.
    Kawashima K
    Nihon Ika Daigaku Zasshi; 1988 Apr; 55(2):191-200. PubMed ID: 3392169
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of Sjögren's disease in NZB/NZW F1 hybrid mice with azathioprine: a two-stage study.
    Yeoman CM; Franklin CD
    Clin Exp Rheumatol; 1994; 12(1):49-53. PubMed ID: 8162642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bromhexine in symptomatic treatment of Sjögren syndrome].
    Fossaluzza V
    Klin Monbl Augenheilkd; 1984 Oct; 185(4):292-5. PubMed ID: 6513403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.